Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
Peter Marks’ ouster comes at a time when the sector is already suffering through a years-long public markets slump.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results